36 /100
MEDIUM RISK
Score updated Jul 14, 2026

CLLS — Cellectis S.A. Dilution Risk Tracker

Track CLLS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CLLS — Get alerts when the score changes →

As of July 14, 2026, Cellectis S.A. (CLLS) has a DilutionWatch DilutionScore of 36/100, rated MEDIUM dilution risk. Cellectis S.A. has a market capitalization of $354.15M, 71.75M shares outstanding, 33 institutional holders tracked.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
46
💰 Cash Runway
40
📊 Float Risk
2
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for CLLS.
🔔 Track CLLS — Get forecast alerts →

💹 Market Data

Market Cap$354.15M
Shares Outstanding71.75M
Float64.64M
Cash$34.84M
Debt$32.20M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 1.0% shares (2026Q1 vs prior)
33 institutional holders · 10.44M shares
#1 B Group, Inc. 3.28M shares
#2 UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 3.18M shares
#3 Long Focus Capital Management, LLC 2.74M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest321.9K
Days to Cover8.9
% of Float0.5%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

No recent SEC insights

📰 Recent News

No recent news

📋 What This Means for CLLS Shareholders

Cellectis S.A. (CLLS) has a DilutionScore of 36/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 14, 2026.

DilutionWatch's EDGAR monitoring for CLLS shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for CLLS in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for CLLS alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track CLLS Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CLLS — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for CLLS
📊 CLLS FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 CLLS Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.